Patt1, a novel protein acetyltransferase that is highly expressed in liver and downregulated in hepatocellular carcinoma, enhances apoptosis of hepatoma cells

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 12, 2009, Pages 2528-2537

  Liu, Zhen ^a   Liu, Yang ^a   Wang, Huiqiang ^a   Ge, Xinjian ^a   Jin, Qihuang ^a   Ding, Guanghui ^b   Hu, Yanan ^a   Zhou, Ben ^a   Chen, Zhongjian ^a   Ge, Xuemei ^a   Zhang, Baohua ^c   Man, Xiaobo ^c   Zhai, Qiwei ^a  

^a Chinese Academy of Sciences   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acetyltransferase; Apoptosis; GNAT family; Hepatocellular carcinoma; Liver

Indexed keywords

ACYLTRANSFERASE; GLUTAMIC ACID; HISTONE ACETYLTRANSFERASE; PROTEIN ACETYLTRANSFERASE 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE SPECIFICITY;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; LIVER; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; RNA, SMALL INTERFERING;

EID: 70350521445     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.08.009     Document Type: Article

References (41)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389-3402
2. Bateman A., Coin L., Durbin R., Finn R.D., Hollich V., Griffiths-Jones S., et al. The Pfam protein families database. Nucleic Acids Res 32 (2004) D138-141
3. Black J.C., Mosley A., Kitada T., Washburn M., and Carey M. The SIRT2 deacetylase regulates autoacetylation of p300. Mol Cell 32 (2008) 449-455
4. Cohen H.Y., Lavu S., Bitterman K.J., Hekking B., Imahiyerobo T.A., Miller C., et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13 (2004) 627-638
5. Crowley J.A., Wang Y., Rapoport A.P., and Ning Y. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation. Leukemia 19 (2005) 2344-2345
6. Dwarakanath B.S., Verma A., Bhatt A.N., Parmar V.S., and Raj H.G. Targeting protein acetylation for improving cancer therapy. Indian J Med Res 128 (2008) 13-21
7. Dyda F., Klein D.C., and Hickman A.B. GCN5-related N-acetyltransferases: a structural overview. Annu Rev Biophys Biomol Struct 29 (2000) 81-103
8. Emanuele S., Lauricella M., and Tesoriere G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (review). Int J Oncol 33 (2008) 637-646
9. Ge X., Jin Q., Zhang F., Yan T., and Zhai Q. PCAF acetylates {beta}-catenin and improves its stability. Mol Biol Cell 20 (2009) 419-427
10. Gibbons R.J. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet 14 Spec. No. 1 (2005) R85-R92
11. Grossman S.R. p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268 (2001) 2773-2778
12. Gu W., Luo J., Brooks C.L., Nikolaev A.Y., and Li M. Dynamics of the p53 acetylation pathway. Novartis Found Symp 259 (2004) 197-205 discussion 205-207, 223-225
13. Gu W., and Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 (1997) 595-606
14. Ida K., Kitabayashi I., Taki T., Taniwaki M., Noro K., Yamamoto M., et al. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90 (1997) 4699-4704
15. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102 (2000) 463-473
16. Jin Y., Zeng S.X., Dai M.S., Yang X.J., and Lu H. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem 277 (2002) 30838-30843
17. Joo J.H., Yoon S.Y., Kim J.H., Paik S.G., Min S.R., Lim J.S., et al. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem 103 (2008) 1183-1197
18. Kikuchi H., and Nakayama T. GCN5 and BCR signalling collaborate to induce pre-mature B cell apoptosis through depletion of ICAD and IAP2 and activation of caspase activities. Gene 419 (2008) 48-55
19. Kitabayashi I., Aikawa Y., Yokoyama A., Hosoda F., Nagai M., Kakazu N., et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia 15 (2001) 89-94
20. Kouraklis G., and Theocharis S. Histone deacetylase inhibitors and anticancer therapy. Curr Med Chem Anticancer Agents 2 (2002) 477-484
21. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9 (1999) 40-48
22. Li M., Luo J., Brooks C.L., and Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277 (2002) 50607-50611
23. Lim J.H., Park J.W., and Chun Y.S. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 66 (2006) 10677-10682
24. Marmorstein R. Structural and chemical basis of histone acetylation. Novartis Found Symp 259 (2004) 78-98 discussion 98-101, 163-109
25. Mottet D., and Castronovo V. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25 (2008) 183-189
26. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12 (1996) 1565-1569
27. Neuwald A.F., and Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. Trends Biochem Sci 22 (1997) 154-155
28. Pediconi N., Guerrieri F., Vossio S., Bruno T., Belloni L., Schinzari V., et al. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage. Mol Cell Biol 29 (2009) 1989-1998
29. Pogribny I.P., Tryndyak V.P., Muskhelishvili L., Rusyn I., and Ross S.A. Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J Nutr 137 (2007) 216S-222S
30. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu Rev Biochem 70 (2001) 81-120
31. Santos-Rosa H., Valls E., Kouzarides T., and Martinez-Balbas M. Mechanisms of P/CAF auto-acetylation. Nucleic Acids Res 31 (2003) 4285-4292
32. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64 (2000) 435-459
33. Sunde J.S., Donninger H., Wu K., Johnson M.E., Pestell R.G., Rose G.S., et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res 66 (2006) 8404-8412
34. Sykes S.M., Mellert H.S., Holbert M.A., Li K., Marmorstein R., Lane W.S., et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24 (2006) 841-851
35. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 (1994) 4673-4680
36. Varier R.A., Swaminathan V., Balasubramanyam K., and Kundu T.K. Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy. Biochem Pharmacol 68 (2004) 1215-1220
37. Vetting M.W., S de Carvalho L.P., Yu M., Hegde S.S., Magnet S., Roderick S.L., et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 433 (2005) 212-226
38. Wang L., Tang Y., Cole P.A., and Marmorstein R. Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr Opin Struct Biol 18 (2008) 741-747
39. Wolf E., Vassilev A., Makino Y., Sali A., Nakatani Y., and Burley S.K. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell 94 (1998) 439-449
40. Yang X.J., and Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26 (2007) 5310-5318
41. Yang X.J., and Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene 26 (2007) 5408-5419